Searched for
SEMAGLUTIDE SUPPLY DELAY
Wegovy edges closer to PBS listing in Australia for high-risk obesity patientsA key Australian health committee has recommended Wegovy for subsidized access. This drug targets adults with existing heart conditions and...20 Dec, 2025, 02.52 PM IST- Buy, Sell or Hold: Elara recommends buy on Dr Reddy’s Laboratories; Goldman raises target on Varun BeveragesBrokerages remain positive on select large and mid-cap stocks, including Dr. Reddy’s, Coal India, and Varun Beverages, citing strong earnin...30 Oct, 2025, 09.30 AM IST
- Buy, Sell or Hold: Nuvama initiates coverage on Eureka Forbes; Religare Broking positive on RECBrokerages stay bullish: Nuvama starts Eureka Forbes with Buy (20% upside), Motilal Oswal reaffirms Biocon Buy (13% upside), Religare Broki...17 Sep, 2025, 09.38 AM IST
- Brookfield, EQT close in on Gland Pharma, but rising stock a painThe Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, ...21 Jul, 2025, 05.30 AM IST
- Weight-loss drug Wegovy launches in the UK as Novo Nordisk shares reach new heights amid supply challengesThe Danish pharmaceutical company Novo Nordisk has introduced its weight-loss drug Wegovy to the United Kingdom. This strategic expansion i...04 Sep, 2023, 05.50 PM IST
- How a TikTok trend for weight loss triggered a diabetes drug shortageOn TikTok, some videos featuring the hashtag Ozempic have been viewed more than a million times. Sponsored ads on Google promise weight los...22 Dec, 2022, 02.26 PM IST
Load More
